IC-KDA + ASAD 2025. International Conference of the Korean Dementia Assocition 2025 & 19th International Congress of the Asian Society Against Dementia. May 8th - 10th, 2025. Lotte Hotel World, Seoul, Korea.

Daily Program

검색
* Please choose 1 of 3 options [Session, Name, Title].
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 8 (Thu)
09:30-10:45
Session 1-1

Clinical Use and ARIA Management of Disease-Modifying Treatments for Alzheimer’s Disease

Sapphire Ballroom
(B1F)
Chairperson Hak Young Rhee (Kyung Hee University, Korea)
YoungSoon Yang (Soonchunhyang University, Korea)
09:30-09:50 Introduction of DMT & Appropriate Use Recommendation

Hee-Jin Kim (Hanyang University, Korea)

09:50-10:10 Understanding of ARIA

Young Hee Jung (Hallym University, Korea)

10:10-10:30 Monitoring ARIA: Review of ARIA Cases

Won-Jin Moon (Konkuk University, Korea)

10:30-10:45 Q & A

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 8 (Thu)
11:00-12:30
Session 1-2

Real-World Challenges in Disease-Modifying Treatments for Alzheimer’s Disease

Sapphire Ballroom
(B1F)
Chairperson Jung Lung Hsu (New Taipei Municipal TuCheng Hospital, Taiwan)
Bora Yoon (The Catholic University of Korea, Korea)
11:00-11:15 Disease-modifying Therapy in Atypical Alzheimer's Disease

Jin-Tai Yu (Huashan Hospital, Fudan University, China)

11:15-11:30 Alzheimer’s Disease with Neuropsychiatric Symptoms

Allen Ting Chun Lee (The Chinese University of Hong Kong, Hong Kong SAR)

11:30-11:45 Making the Decision to Discontinue Anti-amyloid Therapy

Ryoko Ihara (Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)

11:45-12:00 Cases in Real World (Korea)

Hee Jin Kim (Sungkyunkwan University, Korea)

12:00-12:15 Memory Impairment: A Diagnostic Challenge in the Absence of Biomarkers

Rachel Chin Yee Cheong (Khoo Teck Puat Hospital, Singapore)

12:15-12:30 When Function Persists but Scores Do Not: Appropriateness of Amyloid-Targeting Therapy in a Practicing Professional with Alzheimer’s Disease

Yung Shuan Lin (Taipei Veterans General Hospital, Taiwan)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 8 (Thu)
12:30-14:00
Lunch

Sapphire Ballroom
(B1F)
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 8 (Thu)
14:00-15:25
Session 2-1

Diagnosis and Pathophysiology of Idiopathic Normal Pressure Hydrocephalus

Sapphire Ballroom
(B1F)
Chairperson Etsuro Mori (Osaka University, Japan)
YongSoo Shim (The Catholic University of Korea, Korea)
14:00-14:25 Overview of CSF Dynamics

Shigeki Yamada (Nagoya City University, Japan)

14:25-14:45 Imaging of iNPH: Review of iNPH Cases

Chong Hyun Suh (University of Ulsan, Korea)

14:45-15:10 Diagnosis of iNPH

Kyunghun Kang (Kyungpook National University, Korea)

15:10-15:25 Q & A

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 8 (Thu)
15:45-16:45
Session 2-2

Comorbidities and Therapeutic Advances in Idiopathic Normal Pressure Hydrocephalus

Sapphire Ballroom
(B1F)
Chairperson Hojin Choi (Hanyang University, Korea)
Bon D. Ku (Catholic Kwandong University, Korea)
15:45-16:10 Clinical and Radiological Features of iNPH with Neurodegenerative Movement Disorders

Taiji Tsunemi (Juntendo University, Japan)

16:10-16:35 Advancing the Treatment of Idiopathic Normal Pressure Hydrocephalus: Innovations, Outcomes, and Future Perspectives

Ki-Su Park (Kyungpook National University, Korea)

16:35-16:45 Q & A

Organized by 대한치매학회 Asian Society Against Dementia
Supported by Korea Tourism Organization SEOUL METROPOLITAN GOVERNMENT